EX-32.1 6 tmb-20241231xex32d1.htm EX-32.1

EXHIBIT 32.1

​

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

​

AS ADOPTED PURSUANT TO

​

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

​

In connection with the Annual Report on Form 10-K of Mustang Bio, Inc. (the “Company”) for the period ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Manuel Litchman, M.D., President, Chief Executive Officer and Interim Chief Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

​

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

​

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Report.

Dated: March 28, 2025 | By: | /s/ Manuel Litchman
|  | Manuel Litchman, M.D.,
|  | President, Chief Executive Officer and Interim Chief Financial Officer
|  | (Principal Executive Officer and Principal Financial and Accounting Officer)

​

​